Trivalent Inactivated Influenza Vaccine Effective Against Influenza A(H3N2) Variant Viruses in Children During the 2014/15 Season, Japan

Eurosurveillance - France
doi 10.2807/1560-7917.es.2016.21.42.30377
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Centre for Disease Control and Prevention (ECDC)

Related search

Efficacy of Trivalent, Cold-Adapted, Influenza Virus Vaccine Against Influenza a (Fujian), a Drift Variant, During 2003–2004

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2007English

538 Severity of Breakthrough Influenza Illness Among Children and Adults Receiving Live Attenuated Influenza Vaccine and Trivalent Inactivated Influenza Vaccine

Pediatric Research
Child HealthPediatricsPerinatology
2010English

Trivalent Inactivated Influenza Vaccine Is Not Associated With Sickle Cell Crises in Children

Pediatrics
Child HealthPediatricsPerinatology
2011English

Comparative Immunogenicity of the 2014–2015 Northern Hemisphere Trivalent IIV and LAIV Against Influenza a Viruses in Children

Vaccines
Drug DiscoveryInfectious DiseasesImmunologyPharmacology
2019English

Safety of Trivalent Inactivated Influenza Vaccine in Children Aged 24 to 59 Months in the Vaccine Safety Datalink

Archives of Pediatrics & Adolescent Medicine
2011English

Immunogenicity, Safety and Consistency of New Trivalent Inactivated Influenza Vaccine

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2008English

Cross-Reactive Antibody to Swine Influenza A(H3N2) Subtype Virus in Children and Adults Before and After Immunisation With 2010/11 Trivalent Inactivated Influenza Vaccine in Canada, August to November 2010

Eurosurveillance
EnvironmentalVirologyPublic HealthEpidemiologyMedicineOccupational Health
2012English

Phase I Clinical Evaluation of Seasonal Influenza Hemagglutinin (HA) DNA Vaccine Prime Followed by Trivalent Influenza Inactivated Vaccine (IIV3) Boost

Contemporary Clinical Trials
MedicinePharmacology
2015English

Genetic and Antigenic Characterization of Influenza A(H3N2) in Cameroon During the 2014-2016 Influenza Seasons

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy